Logo image of CNR

CORE NATURAL RESOURCES INC (CNR) Stock Fundamental Analysis

NYSE:CNR - US2189371006 - Common Stock

72.84 USD
+0.04 (+0.05%)
Last: 8/28/2025, 8:04:00 PM
72.84 USD
0 (0%)
After Hours: 8/28/2025, 8:04:00 PM
Fundamental Rating

5

Overall CNR gets a fundamental rating of 5 out of 10. We evaluated CNR against 208 industry peers in the Oil, Gas & Consumable Fuels industry. CNR has only an average score on both its financial health and profitability. CNR is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

CNR had positive earnings in the past year.
In the past year CNR had a positive cash flow from operations.
CNR had positive earnings in 4 of the past 5 years.
CNR had a positive operating cash flow in each of the past 5 years.
CNR Yearly Net Income VS EBIT VS OCF VS FCFCNR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M

1.2 Ratios

CNR has a worse Return On Assets (0.33%) than 66.35% of its industry peers.
CNR has a Return On Equity of 0.55%. This is in the lower half of the industry: CNR underperforms 65.38% of its industry peers.
With a Return On Invested Capital value of 1.90%, CNR is not doing good in the industry: 71.63% of the companies in the same industry are doing better.
The Average Return On Invested Capital over the past 3 years for CNR is in line with the industry average of 23.39%.
The 3 year average ROIC (24.39%) for CNR is well above the current ROIC(1.90%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 0.33%
ROE 0.55%
ROIC 1.9%
ROA(3y)17.24%
ROA(5y)10.53%
ROE(3y)35.71%
ROE(5y)22.09%
ROIC(3y)24.39%
ROIC(5y)15.83%
CNR Yearly ROA, ROE, ROICCNR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

1.3 Margins

CNR's Profit Margin of 0.63% is on the low side compared to the rest of the industry. CNR is outperformed by 65.38% of its industry peers.
In the last couple of years the Profit Margin of CNR has grown nicely.
CNR has a Operating Margin of 3.73%. This is in the lower half of the industry: CNR underperforms 70.67% of its industry peers.
In the last couple of years the Operating Margin of CNR has grown nicely.
With a Gross Margin value of 20.38%, CNR is not doing good in the industry: 67.31% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of CNR has declined.
Industry RankSector Rank
OM 3.73%
PM (TTM) 0.63%
GM 20.38%
OM growth 3Y12.32%
OM growth 5Y2.74%
PM growth 3Y70.14%
PM growth 5Y19.45%
GM growth 3Y-31.09%
GM growth 5Y-21.12%
CNR Yearly Profit, Operating, Gross MarginsCNR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60 80

6

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) well above the Cost of Capital (WACC), CNR is creating value.
The number of shares outstanding for CNR has been reduced compared to 1 year ago.
The number of shares outstanding for CNR has been increased compared to 5 years ago.
The debt/assets ratio for CNR has been reduced compared to a year ago.
CNR Yearly Shares OutstandingCNR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
CNR Yearly Total Debt VS Total AssetsCNR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

CNR has an Altman-Z score of 1.83. This is not the best score and indicates that CNR is in the grey zone with still only limited risk for bankruptcy at the moment.
CNR's Altman-Z score of 1.83 is fine compared to the rest of the industry. CNR outperforms 63.94% of its industry peers.
CNR has a debt to FCF ratio of 2.46. This is a good value and a sign of high solvency as CNR would need 2.46 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 2.46, CNR is in the better half of the industry, outperforming 78.37% of the companies in the same industry.
A Debt/Equity ratio of 0.09 indicates that CNR is not too dependend on debt financing.
CNR has a Debt to Equity ratio of 0.09. This is in the better half of the industry: CNR outperforms 78.85% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 2.46
Altman-Z 1.83
ROIC/WACC0.2
WACC9.48%
CNR Yearly LT Debt VS Equity VS FCFCNR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B

2.3 Liquidity

A Current Ratio of 1.78 indicates that CNR should not have too much problems paying its short term obligations.
The Current ratio of CNR (1.78) is better than 72.60% of its industry peers.
A Quick Ratio of 1.25 indicates that CNR should not have too much problems paying its short term obligations.
With a decent Quick ratio value of 1.25, CNR is doing good in the industry, outperforming 64.42% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.78
Quick Ratio 1.25
CNR Yearly Current Assets VS Current LiabilitesCNR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

7

3. Growth

3.1 Past

The earnings per share for CNR have decreased strongly by -74.91% in the last year.
The Earnings Per Share has been growing by 22.60% on average over the past years. This is a very strong growth
CNR shows a strong growth in Revenue. In the last year, the Revenue has grown by 45.25%.
The Revenue has been growing by 9.16% on average over the past years. This is quite good.
EPS 1Y (TTM)-74.91%
EPS 3Y93.33%
EPS 5Y22.6%
EPS Q2Q%-135.71%
Revenue 1Y (TTM)45.25%
Revenue growth 3Y19.47%
Revenue growth 5Y9.16%
Sales Q2Q%119.98%

3.2 Future

CNR is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 9.84% yearly.
The Revenue is expected to grow by 24.91% on average over the next years. This is a very strong growth
EPS Next Y-110.26%
EPS Next 2Y6.06%
EPS Next 3Y8.3%
EPS Next 5Y9.84%
Revenue Next Year77.87%
Revenue Next 2Y39.37%
Revenue Next 3Y24.91%
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
CNR Yearly Revenue VS EstimatesCNR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B 4B
CNR Yearly EPS VS EstimatesCNR Yearly EPS VS EstimatesYearly EPS VS Estimates 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10 15

4

4. Valuation

4.1 Price/Earnings Ratio

A Price/Earnings ratio of 21.49 indicates a rather expensive valuation of CNR.
The rest of the industry has a similar Price/Earnings ratio as CNR.
CNR is valuated rather cheaply when we compare the Price/Earnings ratio to 27.17, which is the current average of the S&P500 Index.
A Price/Forward Earnings ratio of 6.74 indicates a rather cheap valuation of CNR.
88.94% of the companies in the same industry are more expensive than CNR, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of CNR to the average of the S&P500 Index (22.78), we can say CNR is valued rather cheaply.
Industry RankSector Rank
PE 21.49
Fwd PE 6.74
CNR Price Earnings VS Forward Price EarningsCNR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of CNR indicates a somewhat cheap valuation: CNR is cheaper than 60.58% of the companies listed in the same industry.
CNR's Price/Free Cash Flow ratio is in line with the industry average.
Industry RankSector Rank
P/FCF 23.59
EV/EBITDA 7.1
CNR Per share dataCNR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)0.95
EPS Next 2Y6.06%
EPS Next 3Y8.3%

0

5. Dividend

5.1 Amount

CNR has a yearly dividend return of 0.79%, which is pretty low.
CNR's Dividend Yield is slightly below the industry average, which is at 6.33.
With a Dividend Yield of 0.79, CNR pays less dividend than the S&P500 average, which is at 2.34.
Industry RankSector Rank
Dividend Yield 0.79%

5.2 History

CNR has been paying a dividend for less than 5 years, so it still needs to build a track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
CNR Yearly Dividends per shareCNR Yearly Dividends per shareYearly Dividends per share 2022 2023 2024 2025 0.5 1 1.5 2 2.5

5.3 Sustainability

CNR pays out 148.79% of its income as dividend. This is not a sustainable payout ratio.
DP148.79%
EPS Next 2Y6.06%
EPS Next 3Y8.3%
CNR Yearly Income VS Free CF VS DividendCNR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M
CNR Dividend Payout.CNR Dividend Payout, showing the Payout Ratio.CNR Dividend Payout.PayoutRetained Earnings

CORE NATURAL RESOURCES INC

NYSE:CNR (8/28/2025, 8:04:00 PM)

After market: 72.84 0 (0%)

72.84

+0.04 (+0.05%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)08-05 2025-08-05/bmo
Earnings (Next)11-03 2025-11-03/bmo
Inst Owners91.64%
Inst Owner Change-0.38%
Ins Owners1.83%
Ins Owner Change-5.78%
Market Cap3.75B
Analysts77.5
Price Target96.65 (32.69%)
Short Float %5.58%
Short Ratio3.19
Dividend
Industry RankSector Rank
Dividend Yield 0.79%
Yearly Dividend0.53
Dividend Growth(5Y)N/A
DP148.79%
Div Incr Years0
Div Non Decr Years0
Ex-Date08-29 2025-08-29 (0.1)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-131.7%
Min EPS beat(2)-152.91%
Max EPS beat(2)-110.49%
EPS beat(4)1
Avg EPS beat(4)-81.06%
Min EPS beat(4)-152.91%
Max EPS beat(4)0.73%
EPS beat(8)4
Avg EPS beat(8)-28.75%
EPS beat(12)8
Avg EPS beat(12)-8.12%
EPS beat(16)10
Avg EPS beat(16)-37.66%
Revenue beat(2)2
Avg Revenue beat(2)7.34%
Min Revenue beat(2)2.77%
Max Revenue beat(2)11.91%
Revenue beat(4)3
Avg Revenue beat(4)-1.81%
Min Revenue beat(4)-24.65%
Max Revenue beat(4)11.91%
Revenue beat(8)6
Avg Revenue beat(8)1.77%
Revenue beat(12)10
Avg Revenue beat(12)5.56%
Revenue beat(16)13
Avg Revenue beat(16)9.28%
PT rev (1m)4.7%
PT rev (3m)-7.11%
EPS NQ rev (1m)-105.08%
EPS NQ rev (3m)-104.17%
EPS NY rev (1m)-117.74%
EPS NY rev (3m)-111.09%
Revenue NQ rev (1m)-2.76%
Revenue NQ rev (3m)-9.16%
Revenue NY rev (1m)2.1%
Revenue NY rev (3m)2.65%
Valuation
Industry RankSector Rank
PE 21.49
Fwd PE 6.74
P/S 1.14
P/FCF 23.59
P/OCF 9.54
P/B 1
P/tB 1
EV/EBITDA 7.1
EPS(TTM)3.39
EY4.65%
EPS(NY)10.81
Fwd EY14.84%
FCF(TTM)3.09
FCFY4.24%
OCF(TTM)7.64
OCFY10.49%
SpS63.72
BVpS73.2
TBVpS73.2
PEG (NY)N/A
PEG (5Y)0.95
Profitability
Industry RankSector Rank
ROA 0.33%
ROE 0.55%
ROCE 2.22%
ROIC 1.9%
ROICexc 2.06%
ROICexgc 2.06%
OM 3.73%
PM (TTM) 0.63%
GM 20.38%
FCFM 4.85%
ROA(3y)17.24%
ROA(5y)10.53%
ROE(3y)35.71%
ROE(5y)22.09%
ROIC(3y)24.39%
ROIC(5y)15.83%
ROICexc(3y)28.23%
ROICexc(5y)18.22%
ROICexgc(3y)28.23%
ROICexgc(5y)N/A
ROCE(3y)28.54%
ROCE(5y)18.52%
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3Y35.93%
ROICexc growth 5Y15.67%
OM growth 3Y12.32%
OM growth 5Y2.74%
PM growth 3Y70.14%
PM growth 5Y19.45%
GM growth 3Y-31.09%
GM growth 5Y-21.12%
F-Score6
Asset Turnover0.53
Health
Industry RankSector Rank
Debt/Equity 0.09
Debt/FCF 2.46
Debt/EBITDA 0.64
Cap/Depr 58.19%
Cap/Sales 7.14%
Interest Coverage 250
Cash Conversion 74.92%
Profit Quality 770.76%
Current Ratio 1.78
Quick Ratio 1.25
Altman-Z 1.83
F-Score6
WACC9.48%
ROIC/WACC0.2
Cap/Depr(3y)74.91%
Cap/Depr(5y)64.93%
Cap/Sales(3y)7.37%
Cap/Sales(5y)8.18%
Profit Quality(3y)104.03%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-74.91%
EPS 3Y93.33%
EPS 5Y22.6%
EPS Q2Q%-135.71%
EPS Next Y-110.26%
EPS Next 2Y6.06%
EPS Next 3Y8.3%
EPS Next 5Y9.84%
Revenue 1Y (TTM)45.25%
Revenue growth 3Y19.47%
Revenue growth 5Y9.16%
Sales Q2Q%119.98%
Revenue Next Year77.87%
Revenue Next 2Y39.37%
Revenue Next 3Y24.91%
Revenue Next 5YN/A
EBIT growth 1Y-74.63%
EBIT growth 3Y34.19%
EBIT growth 5Y12.15%
EBIT Next Year42.13%
EBIT Next 3Y33.76%
EBIT Next 5Y24.71%
FCF growth 1Y-73.9%
FCF growth 3Y19.97%
FCF growth 5Y31.85%
OCF growth 1Y-49.63%
OCF growth 3Y15.95%
OCF growth 5Y14.26%